Merck & Google Cloud: A Billion-Dollar AI Partnership

0:00Merck just dropped a major collab with Google Cloud to supercharge their AI game and drug-making. They're committing up to $1 billion over the next several years for AI infrastructure, top engineers, and access to Google's Gemini's enterprise platform. This move aims to turbo boost everything from research to sales. The deal got announced that Google's cloud next conference in Las Vegas this week. It builds right on work. The two companies already had cooking, with Google engineers jumping in to team up directly with Merck squads on the ground. Merck's chief info and digital officer, Dave Williams, laid it out clear. Their eye at least a decade of his partnership, not some short test. Run. Google Cloud CEO, Thomas Curian, called it a win for society. Blending Merck's deep drug know-how with their AI tools to hunt down Cures faster. After rolling AI into drug research, regulatory filings, manufacturing, and even commercial

1:00ops. Merck's already using it to slash clinical study reports and reimbursement dossiers, cutting time and costs by half in some markets. And now there, scaling that globally. This alliance has Merck poised to rethink the whole drug pipeline, from lab sims to approvals, making breakthroughs hit shelves quicker than ever. Google News, powered by AI. This is Canada News Today. I'm Corey with the story.